Skip to main content

Table 2 Hospital management of cancer patients with venous thromboembolism, during (initial and subsequent) venous thromboembolism-related hospital stays

From: Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database

Cancer

Pancreas

Lung

Upper gastrointestinal

Lower gastrointestinal

Breast

Arrival at the hospital through the emergency room, yes (%)

1,495 (32%)

4,207 (35%)

974 (32%)

3,166 (34%)

1,666 (35%)

Duration of the index hospital stay

    mean (± SD), days

12.0 (± 13.3)

11.8 (± 13.8)

15.2 (± 18.9)

13.1 (± 16.1)

10.1 (± 12.9)

    median [1st and 3rd quartiles], days

8 [3-18]

8 [3-16]

10 [3-20]

8 [3-17]

6 [2-13]

Hospital departments visited, n (%)

 Resuscitation department

9 (< 1%)

48 (1%)

13 (1%)

49 (1%)

11 (< 1%)

 Intensive care unit

55 (2%)

221 (3%)

58 (3%)

172 (3%)

101 (3%)

 Continuous monitoring

49 (2%)

157 (2%)

52 (2%)

177 (3%)

47 (1%)

Procedures, n (%)

 Vena cava filter insertion

120 (4%)

248 (3%)

120 (5%)

261 (4%)

56 (2%)

 Fibrinolysis

6 (< 1%)

38 (< 1%)

12 (1%)

39 (1%)

8 (< 1%)

 Thromboaspiration

5 (< 1%)

19 (< 1%)

10 (< 1%)

2 (< 1%)

3 (< 1%)

 Thrombectomy

4 (< 1%)

5 (< 1%)

5 (< 1%)

2 (< 1%)

0 (0%)

 None of the above

3,102 (96%)

8,029 (96%)

2,085 (93%)

6,707 (96%)

3,547 (98%)

Discharge mode, n (%)

 Sent home

2,902 (63%)

7,813 (64%)

1,925 (62%)

6,584 (70%)

3,375 (70%)

 Transferred to another unit or hospital

883 (19%)

2,545 (21%)

639 (21%)

1,996 (21%)

993 (21%)

 In hospital mortality

839 (18%)

1,842 (15%)

521 (17%)

855 (9%)

465 (10%)

  1. SD standard deviation
  2. Resuscitation department: intended for patients who present or are likely to present several acute visceral failures directly involving the vital prognosis and requiring the use of substitution methods
  3. Intensive care unit: intended for patients who present or are likely to present one acute failure of the organ concerned by the specialty under which they are treated, directly affecting their vital prognosis in the short term, and involving the use of a method of substitution
  4. Continuous monitoring: intended for patients who, because of the seriousness of their condition or the treatment applied to them, require repeated and systematic clinical and biological observation